Teladoc Health to Participate in Upcoming Investor Conferences
Get Alerts TDOC Hot Sheet
Join SI Premium – FREE
PURCHASE, NY, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced today that Jason Gorevic, chief executive officer, and Mala Murthy, chief financial officer, will participate in the Citi Healthcare Conference on February 24, 2022, and the Cowen Healthcare Conference on March 9, 2022. A live audio webcast and replay of the presentations will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations/.
About Teladoc Health
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Ranked best in KLAS for Virtual Care Platforms in 2021 and #1 among direct-to-consumer telehealth providers in the J.D. Power 2021 U.S. Telehealth Satisfaction Study, Teladoc Health leverages decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com or follow @TeladocHealth on Twitter.
Investors:
Patrick Feeley
914-265-7925
[email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement
- Chicago Child Support Attorney Molly E. Caesar Explains How Illinois Calculates and Enforces Support Orders
- A NEW ICON'S ARRIVAL: GENESIS UNVEILS GV90 FLAGSHIP SUV
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Citi, Twitter, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share